Phase I/II trial of dose reduced capecitabine in elderly or frail patients with untreated advanced colorectal cancer.

被引：0
|
作者：
Breadner, Daniel Adam
Welch, Stephen
Jonker, Derek J.
Klimo, Paul
Cripps, M. Christine
Biagi, James Joseph
Lam, Wendy
Whiston, Frances
Stitt, Larry
Vincent, Mark David
机构：
[1] Schulich Sch Med & Dent, London, ON, Canada
[2] London Reg Canc Program, London, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Continuum Med Care Ltd, W Vancouver, BC, Canada
[5] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada
[6] Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[7] Burnaby Hosp, Reg Canc Ctr, Burnaby, BC, Canada
[8] London Hlth Sci Ctr, London, ON, Canada
[9] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.745
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
745
引用
收藏
页数：1
相关论文
共 50 条
  • [21] WEEKLY OXALIPLATIN AND CAPECITABINE CONTINUOUSLY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC). A PHASE II STUDY
    Pochettino, Paolo
    Bergnolo, Paola
    Boglione, Antonella
    Dal Canton, Orietta
    Cutin, Simona Chiado
    Garetto, Ferdinando
    Biscardi, Emanuela
    Comandone, Alessandro
    ANNALS OF ONCOLOGY, 2004, 15 : 61 - 61
  • [22] A phase I dose-escalation and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced cancer.
    Leong, S.
    Camidge, R.
    Eckhardt, G.
    Basche, M.
    Musib, L.
    Darstein, C.
    Thornton, D.
    Britten, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 91S - 91S
  • [23] Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
    Shin, Sang Joon
    Jeong, Jae Heon
    Park, Young Suk
    Lee, Kyung Hee
    Shim, Byoung Yong
    Kim, Tae Won
    Oh, Do Youn
    Lee, Myung Ah
    Kim, Yong Tai
    Kim, Yeul Hong
    Zang, Dae Young
    Roh, Jae Kyung
    Ahn, Joong Bae
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (05) : 1073 - 1080
  • [24] Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer
    Sang Joon Shin
    Jae Heon Jeong
    Young Suk Park
    Kyung Hee Lee
    Byoung Yong Shim
    Tae Won Kim
    Do Youn Oh
    Myung Ah Lee
    Yong Tai Kim
    Yeul Hong Kim
    Dae Young Zang
    Jae Kyung Roh
    Joong Bae Ahn
    Investigational New Drugs, 2011, 29 : 1073 - 1080
  • [25] Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer
    Kindler, HL
    Friberg, G
    Skoog, L
    Wade-Oliver, K
    Vokes, EE
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2005, 28 (04): : 340 - 344
  • [26] A phase II trial of lapatinib and capecitabine for patients with refractory advanced colorectal adenocarcinoma
    Frank, D. J.
    LoConte, N. K.
    Brooks, W.
    Kim, K.
    Mulkerin, D.
    Schelman, W. R.
    Jumonville, A.
    Holen, K. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Phase I/II trial of capecitabine and gefitinib in patients with advanced colorectal cancer after failure of first-line therapy
    Gravalos, C.
    Escudero, P.
    Jimeno, A.
    Sevilla, I.
    Vega-Villegas, M. E.
    Alonso, V.
    Juez, I.
    Garcia-Carbonero, R.
    Bovio, H.
    Cortes-Funes, H.
    EJC SUPPLEMENTS, 2005, 3 (02): : 198 - 199
  • [28] A phase II trial of capecitabine (X) and irinotecan (I), in a biweekly schedule, for patients (Pts) with advanced/metastatic colorectal cancer (MCRC).
    Garcia-Alfonso, P
    Gonzalez-Arenas, C
    Gonzalez-Flores, E
    Molina, M
    Muñoz, A
    Abad, G
    Garcia-Adrian, S
    Lopez, P
    Belon, J
    Perez-Manga, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 290S - 290S
  • [29] Phase I/II trial of capecitabine and gefitinib in patients with advanced colorectal cancer after failure of first-line therapy
    Jimeno, A
    Sevilla, I
    Gravalos, C
    Vega, ME
    Escudero, P
    Torre, E
    Rivera, F
    de Paredes, MLG
    Colomer, R
    Cortes-Funes, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 235S - 235S
  • [30] A Phase I/II Study of Capecitabine Given on a Week on/Week off Schedule Combined With Bevacizumab and Oxaliplatin for Patients With Untreated Advanced Colorectal Cancer
    Sehgal, Rajesh
    Lembersky, Barry C.
    Rajasenan, Kiran K.
    Crandall, Theodore L.
    Balaban, Edward P.
    Pinkerton, Richard A.
    Kane, Patrick
    Schmotzer, Amy
    Zeh, Herbert
    Potter, Douglas M.
    Ramanathan, Ramesh K.
    CLINICAL COLORECTAL CANCER, 2011, 10 (02) : 117 - 120
12345